secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0001801170-23-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health Q4 revenue $898.8M; Insurance MCR improves to 92.4% from 102.8% YoY
--------------------------------------------------------------------------------

- Full year 2022 Insurance MCR improved to 91.8% from 106.0% in 2021, a 1,420 bps improvement.
- Q4 net loss narrowed to $84.0M from $187.2M; Adjusted EBITDA loss improved to $81.1M from $87.4M.
- 2023 guidance: Insurance MCR 89%-91%, Non-Insurance MCR 98%-100%.
- Consolidated cash and investments $555.3M; parent-level liquidity $331.7M expected to cover 2023 needs.
- Non-Insurance MCR remained above 100% at 103.6% in Q4 and 103.4% for full year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/0001801170-23-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117023000012/clov-20230228.htm
  HTML page:      https://secwatch.observer/filing/0001801170-23-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer